Signals
Platform Powered By EquityPandit

Cash Intraday
Signals

Option
Signals

Stock Future
Intraday Signals

Swing Trading
Signals

Investment
Opportunities

Stock
Signals

Join Now

Orchid Pharma Ltd

NSE :ORCHPHARMA   BSE :524372  Sector : Pharmaceuticals
Buy, Sell or Hold ORCHPHARMA? Ask The Analyst

BSE

prev close

OPEN PRICE

bid price (qty)

offer price (qty)

volume

Today's low / high

52 WK low / high

NSE

prev close

open price

bid price (qty)

offer price (qty)

volume

Today's' low / high

52 WK low / high

25 Nov
1516.20
(3.97%)
22 Nov
1458.35
(-1.30%)
21 Nov
1477.60
(2.55%)
19 Nov
1440.90
(1.38%)
18 Nov
1421.30
(-1.33%)
14 Nov
1440.40
(-0.75%)
13 Nov
1451.25
(-2.06%)
12 Nov
1481.70
(2.00%)
11 Nov
1452.70
(-3.11%)
08 Nov
1499.35
(-0.53%)
07 Nov
1507.35
(3.92%)
06 Nov
1450.45
(2.03%)
05 Nov
1421.60
(2.30%)
04 Nov
1389.65
(-3.85%)
01 Nov
1445.25
(-0.86%)
31 Oct
1457.85
(4.79%)
30 Oct
1391.15
(6.17%)
29 Oct
1310.35
(2.11%)
28 Oct
1283.25
(2.27%)
25 Oct
1254.75
(-5.22%)
24 Oct
1323.80
(3.41%)

Price Chart Historical Data Technical Chart

Technical Analysis

Short Term Investors

Very Bullish
Medium Term Investors

Very Bullish
Long Term Investors

Very Bullish

Moving Averages

5 DMA
Bullish

1460.85

10 DMA
Bullish

1461.6

20 DMA
Bullish

1426.7

50 DMA
Bullish

1391.91

100 DMA
Bullish

1370.21

200 DMA
Bullish

1222.5


Intraday Support and Resistance
(Based on Pivot Points) |

Updated On Nov 25, 2024 04:00 PM For Next Trading Session

Pivots Classic Fibonacci Camarilla Woodie DM
R3 1620.66 1572.73 1537.16 - -
R2 1572.73 1543.62 1530.17 1577.65 -
R1 1544.46 1525.64 1523.19 1554.3 1558.6
P 1496.53 1496.53 1496.53 1501.45 1503.6
S1 1468.26 1467.42 1509.22 1478.1 1482.4
S2 1420.33 1449.44 1502.23 1425.25 -
S3 1392.06 1420.33 1495.25 - -

Key Metrics

EPS

23.36

P/E

64.57

P/B

6.02

Dividend Yield

0%

Market Cap

7,690 Cr.

Face Value

10

Book Value

250.68

ROE

3.02%

EBITDA Growth

36.85 Cr.

Debt/Equity

0.25

Shareholding Pattern

  69.84% Total Promoter Holding
16.78% Mutual Fund Holdings
1.94% FIIs
9.93% Non Institution
0.81% Insurance Companies
0% Custodians
0.7% Other Parties

Shareholding History

Quarterly Result (Figures in Rs. Crores)


Orchid Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 207.11 228.21 230.46 251.98 230.22
PROFIT 19.8 29.43 32.96 29.35 27.24
EPS 4.3 6.18 6.81 5.79 5.37

Orchid Pharma Ltd Quaterly Results


Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
INCOME 206.94 228.03 229.99 252.18 230.66
PROFIT 20.24 30.55 33.19 29.1 25.63
EPS 4.4 6.42 6.86 5.74 5.05

Profit & Loss (Figures in Rs. Crores)


Orchid Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1893.37 904.92 804.22 695.72 791.28 526.41 482.36 654.09 746.02 894.12
PROFIT -310.04 -226.56 -409.18 -352.81 -131.52 -131.16 -118.41 -2.46 6.32 92.36
EPS 0 0 0 0 7.8 0 -28.55 0.39 11.88 18.74

Orchid Pharma Ltd Profit & Loss


Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024
INCOME 1882.85 888.65 780.78 661.47 781.08 525.56 472.85 636.67 746.02 893.65
PROFIT -304.43 -221.72 -402.29 -355.32 -125.99 -149.93 -118.13 -5.32 14.19 94.94
EPS 0 0 0 0 -11.36 -36.71 -28.7 -1.18 13.28 18.68

Balance Sheet (Figures in Rs. Crores)

Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 50.7240.8240.8240.8240.8288.9688.9688.9688.9685.26
Reserves Total 1,050.19579.27538543.53725.17-793-880.72-555.71-39.92244.12
Equity Application Money68.5668.5668.5668.56000000
Total Shareholders Funds1,169.47688.65647.38652.91765.99-704.04-791.76-466.7549.04329.38
Secured Loans 14.27264.15207.58389.24491.923,091.653,064.843,104.832,872.292,984.88
Unsecured Loans 120.9167.1960.3863.574.47138.31137.111.33342.3225.78
Total Debt135.18331.34267.96452.74566.393,229.963,201.953,106.163,214.593,210.66
Other Liabilities3.6312.611.0111.5411.797.77.485.923.734.18
Total Liabilities1,308.281,032.59926.351,117.191,344.172,533.622,417.672,645.333,267.363,544.22
APPLICATION OF FUNDS :
Gross Block 1,300.941,220.561,176.391,176.11,247.111,519.481,519.491,636.893,005.873,002.15
Less: Accumulated Depreciation680.71647.47592.68505.66389.18263.22133.28140.341,369.041,206.95
Net Block620.23573.09583.71670.44857.931,256.261,386.211,496.551,636.831,795.2
Capital Work in Progress30.6746.469.787.4325.61278.16271.53288.31280.4281.51
Investments 45.8244.4445.4915.430.340.471.071.140.810.81
Inventories 264.23228.74172.66152.89141.69169.77193.74211.25241.85251.93
Sundry Debtors 195.55215.19170.57135.767.97119.89119.51164.65310.07256.57
Cash and Bank Balance266.5730.638.0619.91174.04325.52305.55257.06314.94390.57
Loans and Advances 64.4126.4546.37226.34185.62152.2760.1442.16384.33379.06
Total Current Assets790.75501.01397.65534.84569.32767.46678.95675.121,251.21,278.12
Current Liabilities 243.51185.9177.98113.31109.27536.56703.44559.51456.35353.73
Provisions 2.083.493.013.523.253.631.031.3344.2252.23
Total Current Liabilities & Provisions245.59189.39180.99116.84112.52540.2704.47560.84500.57405.96
Net Current Assets545.16311.62216.66418456.8227.26-25.52114.29750.63872.16
Deferred Tax Assets086.1182.83149.34197.5240.3294.14000
Deferred Tax Liability089.3386.06152.57200.72243.5497.3749.4294.14111.21
Net Deferred Tax0-3.22-3.23-3.23-3.22-3.22-3.23-49.42-94.14-111.21
Other Assets66.3960.273.949.116.7774.68787.62794.47692.83705.75
Total Assets1,308.281,032.6926.351,117.191,344.172,533.612,417.672,645.333,267.363,544.23
Contingent Liabilities56.9741.9542.8845.120142.9161.53181.2171.32107.03
Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016Mar 2015
SOURCES OF FUNDS :
Share Capital 50.7240.8240.8240.8240.8288.9688.9688.9688.9685.26
Reserves Total 1,099.04622.59568.58571.96688.45-843.95-763.1-431.8882.17354.14
Equity Application Money68.5668.5668.5668.5668.5600000
Total Shareholders Funds1,218.32731.97677.96681.34797.83-754.99-674.14-342.92171.13439.4
Secured Loans 14.05222.59170.63366.84491.923,091.653,064.843,104.833,075.553,054.94
Unsecured Loans 120.91108.7597.3285.974.47138.31137.111.33138.87155.72
Total Debt134.96331.34267.95452.74566.393,229.963,201.953,106.163,214.423,210.66
Other Liabilities3.6312.611.0111.5411.797.77.485.923.734.18
Total Liabilities1,356.911,075.91956.921,145.621,376.012,482.672,535.292,769.163,389.283,654.24
APPLICATION OF FUNDS :
Gross Block 1,297.021,220.451,176.261,175.971,246.981,424.571,424.571,540.432,893.192,889.7
Less : Accumulated Depreciation 680.59647.39592.6505.58389.12263.22133.29138.721,352.831,192.6
Net Block 616.43573.06583.66670.39857.861,161.351,291.281,401.711,540.361,697.1
Capital Work in Progress24.4646.099.787.4325.61278.16271.53288.31280.4281.51
Investments 69.450.1249.0115.430.340.47124.77124.84124.65124.65
Inventories 264.23228.74172.66150.57140.78167.11184.94197.45210.34242.28
Sundry Debtors 189.37211.91160.23131.9666.38140.73145.07208.07375.44290.16
Cash and Bank Balance257.2322.344.2118.97172.32324.17301.04256.04313.11389.57
Loans and Advances 71.4730.8145.99225.73185.29151.4559.7541.5425.23424.78
Total Current Assets782.29493.79383.08527.23564.77783.46690.8703.061,324.121,346.79
Current Liabilities 193.21140.64131.0472.167.51503.73671.21538.43434.88338.17
Provisions 2.083.493.013.523.253.631.031.3344.2252.23
Total Current Liabilities & Provisions195.3144.12134.0575.6270.76507.37672.24539.76479.1390.4
Net Current Assets587349.67249.03451.61494.01276.0918.56163.3845.02956.39
Deferred Tax Assets110.8186.1182.83149.34197.5240.320000
Deferred Tax Liability110.8189.3386.06152.57200.72243.543.2349.4294.14111.39
Net Deferred Tax0-3.22-3.23-3.23-3.22-3.22-3.23-49.42-94.14-111.39
Other Assets59.6260.268.6741.41769.81832.39840.43692.99705.97
Total Assets1,356.911,075.92956.921,145.631,376.012,482.662,535.32,769.163,389.283,654.23
Contingent Liabilities49.1738.6842.8845.120142.9161.53181.2171.32107.03

Cash Flow (Figures in Rs. Crores)

Net Profit before Tax and Extr...89.05
Depreciation33.24
Interest (Net)0.01
P/L on Sales of Assets0.19
Prov. and W/O (Net)0.2
P/L in Forex7.63
Total Adjustments (PBT and Ext...44.15
Operating Profit before Workin...133.2
Trade and 0ther Receivables19.65
Inventories-35.49
Trade Payables54.85
Total Adjustments (OP before W...-7.84
Cash Generated from/(used in) ...125.36
Direct Taxes Paid0.63
Total Adjustments(Cash Generat...0.63
Cash Flow before Extraordinary...125.99
Net Cash from Operating Activi...125.99
Purchased of Fixed Assets-64.81
Purchase of Investments-4.28
Interest Received12
Net Cash used in Investing Act...-312.03
Proceeds from Issue of shares ...391.94
Of the Long Tem Borrowings-208.55
Interest Paid-16.35
Net Cash used in Financing Act...167.04
Net Profit before Tax and Extr...91.52
Depreciation33.22
Interest (Net)0.45
P/L on Sales of Assets0.19
Prov. and W/O (Net)0.2
P/L in Forex7.63
Total Adjustments (PBT and Ext...41.68
Operating Profit before Workin...133.21
Trade and 0ther Receivables25.4
Inventories-35.49
Trade Payables49.93
Total Adjustments (OP before W...-3.22
Cash Generated from/(used in) ...129.99
Direct Taxes Paid0.74
Total Adjustments(Cash Generat...0.74
Cash Flow before Extraordinary...130.73
Net Cash from Operating Activi...130.73
Purchased of Fixed Assets-55.15
Purchase of Investments-19.28
Interest Received11.53
Net Cash used in Investing Act...-315.81
Proceeds from Issue of shares ...391.94
Of the Long Tem Borrowings-208.55
Interest Paid-16.33
Net Cash used in Financing Act...167.07

Company Details

Registered Office
AddressOrchid Towers Nungambakkam,
313 Valluvar Kottam High Road
CityChennai
StateTamil Nadu
Pin Code600034
Tel. No.91-44-28211000/28230000
Fax. No.91-44-28211002
Emailcorporate@orchidpharma.com
Internethttp://www.orchidpharma.com
Registrars
AddressOrchid Towers Nungambakkam
CityChennai
StateTamil Nadu
Pin Code600034
Tel. No.91-44-28211000/28230000
Fax. No.91-44-28211002
Emailcorporate@orchidpharma.com
Internethttp://www.orchidpharma.com
Management
Name Designation
Tanu SinglaIndependent Director
Manoj GoyalIndependent Director
Manish DhanukaManaging Director
Mridul DhanukaWhole-time Director
Ram Gopal AgarwalChairman (Non-Executive)
Arjun DhanukaNon Executive Director
Dharam VirIndependent Director
Shubha SinghIndependent Director